Allogene Therapeutics, Inc. Contracts & Agreements

53 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Asset Contribution Agreement, dated April 2, 2018, by and between the Registrant and Pfizer Inc
Contribution Agreements
Allogene Therapeutics, Inc.
Biotechnology
DE
2018
Underwriting Agreement by and between the Company and Goldman Sachs & Co. LLC, dated May 13, 2024
Underwriting Agreements
Allogene Therapeutics, Inc.
2024
Securities Purchase Agreement by and among the Company and the Purchasers named therein, dated May 13, 2024
Purchase Agreements
Allogene Therapeutics, Inc.
2024
Non-employee director compensation policy, as amended
Compensation Agreements
Allogene Therapeutics, Inc.
2024
Non-Employee Director Compensation Policy
Compensation Agreements
Allogene Therapeutics, Inc.
2024
First Amendment to Consulting Agreement, dated December 16, 2023, by and between the Registrant and Alison Moore, Ph.D
Consulting Agreements
Allogene Therapeutics, Inc.
2024
Amended and Restated Collaboration and License Agreement, dated January 17, 2024, by and between the Registrant and Notch Therapeutics Inc
Collaboration Agreements
Allogene Therapeutics, Inc.
2024
Strategic Collaboration Agreement, dated January 3, 2024, by and between Foresight Diagnostics, Inc. and the Registrant
Collaboration Agreements
Allogene Therapeutics, Inc.
2024
Employment Letter of Agreement, dated August 11, 2023, by and between the Registrant and Earl Douglas
Employment Agreements
Allogene Therapeutics, Inc.
2023
Employment Letter of Agreement, dated October 12, 2023, by and between the Registrant and Geoffrey Parker
Employment Agreements
Allogene Therapeutics, Inc.
2023
Asset Contribution Agreement, dated April 2, 2018, by and between the Registrant and Pfizer Inc
Contribution Agreements
Allogene Therapeutics, Inc.
2023
Amendment No. 2 to Sales Agreement, dated November 2, 2023, by and between the Registrant and Cowen and Company, LLC
Sales Agreements
Allogene Therapeutics, Inc.
2023
Consulting Agreement, dated April
Consulting Agreements
Allogene Therapeutics, Inc.
2023
Consulting Agreement, dated April 29, 2023, by and between the Registrant and Alison Moore, Ph.D
Consulting Agreements
Allogene Therapeutics, Inc.
2023
Employment Letter of Agreement, dated April 18, 2023, by and between the Registrant and Timothy Moore
Employment Agreements
Allogene Therapeutics, Inc.
2023
Description of Common Stock
Stock Agreements
Allogene Therapeutics, Inc.
2023
Employment Letter of Agreement, dated December 28, 2022, by and between the Registrant and Zachary Roberts, M.D., Ph.D
Employment Agreements
Allogene Therapeutics, Inc.
Biotechnology
CA
2023
First Amendment to the Share Purchase Agreement, dated May 11, 2022, by and among the Registrant, Overland Pharmaceuticals (CY) Inc. and Allogene Overland Biopharm (CY) Limited
Share Agreements
Allogene Therapeutics, Inc.
2022
First Amendment, dated December 10, 2021, to the Lease, dated August 1, 2018, by and between the Registrant and Britannia Pointe Grand Limited Partnership
Lease Agreements
Allogene Therapeutics, Inc.
2022
First Amendment, dated December 10, 2021, to the Lease Agreement, dated October 25, 2018, by and between the Registrant and Healthpeak Properties, Inc. (formerly known as HCP,...
Lease Agreements
Allogene Therapeutics, Inc.
Biotechnology
CA
2022
Non-Employee Director Compensation Policy
Compensation Agreements
Allogene Therapeutics, Inc.
Biotechnology
2021
Exclusive License Agreement, dated December 14, 2020, by and between the Registrant and Allogene Overland Biopharm (CY) Limited
License Agreements
Allogene Therapeutics, Inc.
Biotechnology
DE
2021
Share Purchase Agreement, dated December 14, 2020, by and among the Registrant, Overland Pharmaceuticals (CY) Inc. and Allogene Overland Biopharm (CY) Limited
Share Agreements
Allogene Therapeutics, Inc.
2021
Shareholders' Agreement, dated December 14, 2020, by and among the Registrant, Overland Pharmaceuticals (CY) Inc. and Allogene Overland Biopharm (CY) Limited
Shareholders Agreements
Allogene Therapeutics, Inc.
2021
Second Amendment, dated July 15, 2020, to the Lease Agreement, dated February 19, 2019, by and between the Registrant and Silicon Valley Gateway Technology Center, LLC
Lease Agreements
Allogene Therapeutics, Inc.
2020
Underwriting Agreement, dated June 1, 2020, by and among Goldman Sachs & Co. LLC, Jefferies LLC and Cowen and Company, LLC, as representatives of the several underwriters named...
Underwriting Agreements
Allogene Therapeutics, Inc.
Biotechnology
2020
Employment Letter of Agreement, dated April 30, 2018, by and between the Registrant and Veer Bhavnagri
Employment Agreements
Allogene Therapeutics, Inc.
2020
Description of Common Stock
Stock Agreements
Allogene Therapeutics, Inc.
2020
Non-Employee Director Compensation Policy
Compensation Agreements
Allogene Therapeutics, Inc.
Biotechnology
2020
Employment Letter of Agreement, dated July 29, 2019, by and between the Registrant and Rafael G. Amado, M.D
Employment Agreements
Allogene Therapeutics, Inc.
Biotechnology
CA
2020
Collaboration and License Agreement, dated November 1, 2019, by and between the Registrant and Notch Therapeutics Inc
Collaboration Agreements
Allogene Therapeutics, Inc.
2020
First Amendment, dated September 4, 2019, to the Lease Agreement, dated February 19, 2019, by and between the Registrant and Silicon Valley Gateway Technology Center, LLC
Lease Agreements
Allogene Therapeutics, Inc.
2019
Lease Agreement, dated October 25, 2018, by and between the Registrant and HCP, Inc
Lease Agreements
Allogene Therapeutics, Inc.
Biotechnology
CA
2019
Lease Agreement, dated February 19, 2019, by and between the Registrant and Silicon Valley Gateway Technology Center, LLC
Lease Agreements
Allogene Therapeutics, Inc.
Biotechnology
CA
2019
Form of Underwriting Agreement
Underwriting Agreements
Allogene Therapeutics, Inc.
Biotechnology
2018
Form of Common Stock Certificate of the Registrant
Stock Agreements
Allogene Therapeutics, Inc.
Biotechnology
2018
Form of Indemnity Agreement by and between the Registrant and its directors and officers
Allogene Therapeutics, Inc.
2018
Indemnification Agreement, dated April 6, 2018, by and between the Registrant and John DeYoung
Indemnification Agreements
Allogene Therapeutics, Inc.
2018
Allogene Therapeutics, Inc. Amended and Restated 2018 Equity Incentive Plan and Forms of Stock Option Grant Notice, Option Agreement, Notice of Exercise, Restricted Stock Unit...
Bonus & Incentive Agreements
Allogene Therapeutics, Inc.
2018
Allogene Therapeutics, Inc. 2018 Employee Stock Purchase Plan
Stock Agreements
Allogene Therapeutics, Inc.
Biotechnology
2018
Allogene Therapeutics, Inc. 2018 Change in Control Plan and Severance Benefit Plan
Change of Control Agreements
Allogene Therapeutics, Inc.
Biotechnology
CA
2018
Non-Employee Director Compensation Policy
Compensation Agreements
Allogene Therapeutics, Inc.
Biotechnology
2018
Exclusive License and Collaboration Agreement, dated October 30, 2015, by and between the Registrant (assignee of Pfizer Inc.) and Les Laboratoires Servier and Institut de...
Collaboration Agreements
Allogene Therapeutics, Inc.
Biotechnology
2018
Investors Rights Agreement, dated April 6, 2018, by and among the Registrant and certain of its securityholders, as amended September 5, 2018
Investor Rights Agreements
Allogene Therapeutics, Inc.
2018
Allogene Therapeutics, Inc. Amended and Restated 2018 Equity Incentive Plan (Prior Plan) and Forms of Stock Option Grant Notice, Option Agreement, Notice of Exercise and Early...
Bonus & Incentive Agreements
Allogene Therapeutics, Inc.
2018
Research Collaboration and License Agreement, dated June 17, 2014, by and between the Registrant (assignee of Pfizer Inc.) and Cellectis SA, as amended
Collaboration Agreements
Allogene Therapeutics, Inc.
Biotechnology
NY
2018
Asset Contribution Agreement, dated April 2, 2018, by and between the Registrant and Pfizer Inc
Contribution Agreements
Allogene Therapeutics, Inc.
Biotechnology
DE
2018
Transition Services Agreement, dated April 6, 2018, by and between the Registrant and Pfizer Inc
Transition Agreements
Allogene Therapeutics, Inc.
Biotechnology
DE
2018
Option for Rights to Retained Territory Letter Agreement, dated April 2, 2018, by and between the Registrant and Pfizer Inc
Allogene Therapeutics, Inc.
2018
Lease, dated August 1, 2018, by and between the Registrant and Britannia Pointe Grand Limited Partnership
Lease Agreements
Allogene Therapeutics, Inc.
2018
Employment Agreement by and between the Registrant and David Chang, M.D., Ph.D
Employment Agreements
Allogene Therapeutics, Inc.
Biotechnology
CA
2018
Employment Agreement by and between the Registrant and Eric Schmidt, Ph.D
Employment Agreements
Allogene Therapeutics, Inc.
Biotechnology
CA
2018
Employment Agreement by and between the Registrant and Alison Moore, Ph.D
Employment Agreements
Allogene Therapeutics, Inc.
Biotechnology
CA
2018